Home

CVS Health Corp (CVS)

75.77
+1.16 (1.55%)
NYSE · Last Trade: Sep 28th, 8:00 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Healthcare Sector Reels: A Deep Dive into Thursday's -1.67% Plunge
The healthcare sector experienced a significant downturn on Thursday, September 25, 2025, shedding a notable -1.67% of its value and sending ripples of concern through the broader financial markets. This sharp decline, which outpaced the overall market's performance, immediately signaled investor apprehension regarding a sector traditionally viewed as defensive
Via MarketMinute · September 26, 2025
CMS Unleashes AI on Medicare: New Program Sparks Debate Over Cost Savings vs. Patient Care
The Centers for Medicare & Medicaid Services (CMS) is poised to usher in a new era of healthcare administration with the upcoming launch of the Wasteful and Inappropriate Service Reduction (WISeR) Model. This groundbreaking pilot program, set to begin on January 1, 2026, will integrate artificial intelligence (AI) into the prior
Via MarketMinute · September 25, 2025
CVS Health Gains as Revenue Grows, Dividend Remains Strongmarketbeat.com
CVS has broken past 52-week highs, and chances are this newfound optimism is going to carry the stock even higher in the coming quarters.
Via MarketBeat · September 25, 2025
AI's Double-Edged Scalpel: Revolutionizing Healthcare While Igniting Controversy
The healthcare sector stands on the precipice of a monumental transformation, driven by the relentless advance of Artificial Intelligence (AI). From streamlining administrative tasks to enhancing diagnostic accuracy, AI promises a future of more efficient, accessible, and personalized care. However, this technological revolution is not without its complexities, sparking debates
Via MarketMinute · September 24, 2025
UnitedHealth Group's Tumultuous Quarter: A Bellwether for Healthcare Payer Crisis
The healthcare payer industry is reeling following a challenging second quarter, epitomized by UnitedHealth Group's (NYSE: UNH) significant earnings miss and the deepening shadow of a federal Medicare fraud investigation. These developments are not isolated incidents but rather stark indicators of mounting pressures within the health insurance sector, characterized by
Via MarketMinute · September 22, 2025
Healthcare Sector Outlook: Navigating Regulatory Headwinds and Breakthrough Innovations
The healthcare sector is currently experiencing a period of profound transformation, marked by a fascinating dichotomy: groundbreaking medical innovations are driving unprecedented growth for some, while intense regulatory scrutiny and escalating costs pose significant challenges for others. This intricate interplay between scientific advancement and a complex operating environment is reshaping
Via MarketMinute · September 22, 2025
Aetna Expands Hospital Program To Cut Readmissionsbenzinga.com
Aetna, a CVS Health unit, is expanding its Clinical Collaboration program to 10 hospitals to cut readmissions.
Via Benzinga · September 22, 2025
UnitedHealth Group Navigates Turbulent Waters: Q3 2025 EPS Under Significant Pressure Amidst Mounting Headwinds
UnitedHealth Group (NYSE: UNH), a titan in the U.S. healthcare industry, is grappling with a formidable array of financial and operational challenges that are poised to exert immediate and substantial downward pressure on its Q3 2025 Earnings Per Share (EPS) estimates. A confluence of escalating high-acuity care costs, unfavorable
Via MarketMinute · September 19, 2025
UnitedHealth Group Under Siege: DOJ Probes and Cyberattack Aftermath Shake Healthcare Giant
UnitedHealth Group (NYSE: UNH), a dominant force in the U.S. healthcare landscape, is currently embroiled in an unprecedented storm of regulatory and legal scrutiny. Federal Justice Department probes targeting its expansive vertical integration and Medicare Advantage billing practices are intensifying, while the company continues to reel from the catastrophic
Via MarketMinute · September 19, 2025
Uncover the latest developments among S&P500 stocks in today's session.chartmill.com
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday.
Via Chartmill · September 19, 2025
CVS HEALTH CORP (NYSE:CVS) Shows Strong Technical Setup for Breakoutchartmill.com
CVS stock shows strong technicals with a high setup rating, indicating a potential breakout from its current consolidation pattern near 52-week highs.
Via Chartmill · September 19, 2025
3 Profitable Stocks That Concern Us
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
Via StockStory · September 17, 2025
Q2 Earnings Outperformers: UnitedHealth (NYSE:UNH) And The Rest Of The Health Insurance Providers Stocks
Let’s dig into the relative performance of UnitedHealth (NYSE:UNH) and its peers as we unravel the now-completed Q2 health insurance providers earnings season.
Via StockStory · September 16, 2025
What's going on in today's session: S&P500 moverschartmill.com
Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via Chartmill · September 15, 2025
These S&P500 stocks are gapping in today's sessionchartmill.com
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Monday. Stay informed about the latest market trends.
Via Chartmill · September 15, 2025
This Healthcare Stock Is Soaringfool.com
CVS is firing on all cylinders.
Via The Motley Fool · September 13, 2025
Q2 Earnings Highs And Lows: McKesson (NYSE:MCK) Vs The Rest Of The Healthcare Providers & Services Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at McKesson (NYSE:MCK) and the best and worst performers in the healthcare providers & services industry.
Via StockStory · September 10, 2025
Why CVS Health (CVS) Stock Is Up Today
Shares of diversified healthcare company CVS Health (NYSE:CVS) jumped 2.9% in the afternoon session after broad positive sentiment in the healthcare sector was supported by a bullish analyst outlook. 
Via StockStory · September 9, 2025
Stock Of The Day: Is CVS Headed Higher?benzinga.com
CVS Health Corporation reverses off of support around the $70 level. There is support at this level because it was resistance.
Via Benzinga · September 9, 2025
3 Overrated Stocks with Warning Signs
Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.
Via StockStory · September 9, 2025
Reflecting On Health Insurance Providers Stocks’ Q2 Earnings: Oscar Health (NYSE:OSCR)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Oscar Health (NYSE:OSCR) and the best and worst performers in the health insurance providers industry.
Via StockStory · September 8, 2025
Why CVS Health (CVS) Stock Is Falling Today
Shares of diversified healthcare company CVS Health (NYSE:CVS) fell 4.8% in the afternoon session after two Republican congressmen launched an investigation into the company over concerns it may have violated the HIPAA privacy law. 
Via StockStory · September 8, 2025
What's going on in today's session: S&P500 moverschartmill.com
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Monday as we examine the latest happenings in today's session.
Via Chartmill · September 8, 2025
Discover which S&P500 stocks are making waves on Monday.chartmill.com
Curious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session.
Via Chartmill · September 8, 2025
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricingbenzinga.com
Mark Cuban explains how PBMs & wholesalers force pharmacies into exclusive deals, creating a 'stranglehold' on prescription drug prices.
Via Benzinga · September 8, 2025